Cover Image
市場調查報告書

糖尿病相關設備市場分析:設備類別 (血糖自我檢測·診斷設備),給藥類別 (注射器,幫浦,筆,注射器),各市場區隔的預測

Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor (CGM) And Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 361265
出版日期 內容資訊 英文 81 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
糖尿病相關設備市場分析:設備類別 (血糖自我檢測·診斷設備),給藥類別 (注射器,幫浦,筆,注射器),各市場區隔的預測 Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor (CGM) And Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024
出版日期: 2016年05月31日 內容資訊: 英文 81 Pages
簡介

全球糖尿病相關設備市場預測在2024年前將達到355億美元。

本報告提供全球糖尿病相關設備市場相關調查分析,提供您產業預測,各市場區隔預測,加上競爭情形等相關的系統性資訊。

第1章 調查手法和範圍

第2章 摘要整理

第3章 糖尿病相關設備市場:產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場動態
  • 推動市場要素分析
    • 阻礙市場要素分析
  • 主要的優先的機會
  • 五力分析模型
  • PESTEL分析
  • 企業的市場佔有率分析
  • 價值鏈分析

第4章 糖尿病相關設備市場:各產品預測

  • 各產品
  • 監測·診斷設備
  • 胰島素給藥設備

第5章 糖尿病相關設備市場:各地區的預測

  • 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 競爭情形

  • 企業簡介 (企業概要,財務實際成果,產品基準,策略性構想)
    • Abbott laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Johnson and Johnson
    • Bayer HealthCare AG
    • Becton, Dickinson and Company
    • Medtronic Inc.
    • Novo Nordisk A/S
    • Sanofi

圖表

目錄
Product Code: 978-1-68038-873-2

The global diabetes devices market is expected to reach USD 35.5 billion by the year 2024, according to a new report published by Grand View Research, Inc. Major drivers of the market include the growing number of diabetic patients owing to the sedentary lifestyles and unhealthy food habits. The growing demand for the advanced and minimally invasive, diagnostic as well as monitoring devices is expected to propel the market growth during the forecast period.

The rising awareness with regard to the technologically advanced monitoring tools, such as the continuous glucose monitor, is a crucial factor expected to spur the growth of the market. The demand for affordable monitoring devices in the developed as well as the less-developed countries is expected to propel the market growth of products, such as glucose test strips.

The existence of relatively smooth product approval procedures in most of the developed countries including the U.S and European countries are expected to boost the insulin devices market. The rising popularity of the compact, easy to carry monitoring devices, and the introduction of minimally invasive, highly efficient devices is expected to drive the market growth at a lucrative rate. However, the disparity in the reimbursement policies is primarily challenging the overall growth of this market.

Further key findings from the study suggest:

  • The demand for the diabetes devices is expected to surge owing to the factors such as the constantly increasing geriatric population prone to diabetes, the government initiatives taken to support better management of diabetes, and the growing awareness regarding diabetes devices
  • In 2015, the test-strips sub-segment captured the largest market share in the blood glucose monitoring and diagnostic devices segment. The insulin pens accounted for the largest share of the insulin delivery devices segment. The global diabetes devices market is expected to reach USD 35.4 billion in 2024.
  • The monitoring and diagnostic devices segment captured the largest market share of the overall market in 2015. The segment accounted for around 71% of the total market owing to repeat purchases.
  • The monitoring and diagnostic devices segment is expected to maintain its dominance during the forecast period owing to the introduction of technologically advanced products coupled with the high adoption of these products in the near future
  • North America captured the largest market share of around 32% in the year 2015. The domination of the market is expected to continue with a CAGR of 5.9%. The growing diabetic population, the availability of technologically advanced devices, and the presence of skilled professionals are the factors contributing to the growth of the market in North America.
  • Asia Pacific is the fastest growing segment of the market. Countries, such as China and India are expected to show a swift growth owing to the high prevalence of diabetes, the rising awareness regarding commercially available devices, and the growing disposable income in these countries
  • The key players in diabetes devices market include Abbott Laboratories, Inc., Bayer Healthcare AG, Johnson& Johnson, F. Hoffmann La-Roche Ltd., Becton Dickinson and Company, Medtronic, Inc., Novo Nordisk A/S, and Sanofi.

Table of Content

Chapter 1: Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Country wide market: Base estimates
    • 1.1.2. Global market: CAGR calculation
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2: Executive Summary

Chapter 3: Diabetes Devices Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects
  • 3.3. Diabetes Devices: market dynamics
  • 3.4. Market driver analysis
    • 3.4.1. Market restraint analysis
  • 3.5. Key opportunities prioritized
  • 3.6. Diabetes Devices Industry Analysis-Porter's Five Forces Model
  • 3.7. Diabetes Devices Market-PESTEL Analysis
  • 3.8. Diabetes Devices: company market share analysis, 2014
  • 3.9. Value Chain Analysis

Chapter 4: Diabetes Devices Product Outlook

  • 4.1. Diabetes Devices market revenue share by product, 2014 & 2024, % share
  • 4.2. Monitoring and Diagnostic Devices
    • 4.2.1. Monitoring and Diagnostic Devices Market Revenue, by type, 2013-2024(USD Million)
    • 4.2.2. Lancets
      • 4.2.2.1. Lancets Market Revenue, 2013 to 2024(USD Million)
    • 4.2.3. Analog Glucose Meter
      • 4.2.3.1. Analog Glucose Meter Market Revenue, 2013 to 2024(USD Million)
    • 4.2.4. Continues Glucose Monitor(CGM)
      • 4.2.4.1. Continues Glucose Monitor Market Revenue, 2013 to 2024(USD Million)
    • 4.2.5. Test Strips
      • 4.2.5.1. Test Strips Market Revenue, 2013 to 2024(USD Million)
  • 4.3. Insulin Delivery Devices
    • 4.3.1. Insulin Delivery Devices Market Revenue, 2013 to 2024(USD Million)
    • 4.3.2. Syringe
      • 4.3.2.1. Syringe Market Revenue, 2013 to 2024(USD Million)
    • 4.3.3. Pen
      • 4.3.3.1. Pen Market Revenue, 2013 to 2024(USD Million)
    • 4.3.4. Pump
      • 4.3.4.1. Pump Market Revenue, 2013 to 2024(USD Million)
    • 4.3.5. Injector
      • 4.3.5.1. Injector Market Revenue, 2013 to 2024(USD Million)

Chapter 5: Diabetes Devices Market Regional Outlook

  • 5.1. Diabetes Devices market share, by region, 2014 & 2024
  • 5.2. North America
    • 5.2.1. U.S.
    • 5.2.2. Canada
  • 5.3. Europe
    • 5.3.1. UK
    • 5.3.2. Germany
  • 5.4. Asia Pacific
    • 5.4.1. China
    • 5.4.2. India
  • 5.5. Latin America
    • 5.5.1. Brazil
    • 5.5.2. Mexico
  • 5.6. Middle East and Africa(MEA)
    • 5.6.1. South Africa

Chapter 6: Competitive Landscape

  • 6.1. Abbott laboratories Inc.
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. F. Hoffmann-La Roche AG
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Portfolio
    • 6.2.4. Strategic Initiatives
  • 6.3. Johnson and Johnson
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. Bayer HealthCare AG
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Becton, Dickinson and Company
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Medtronic Inc.
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. Novo Nordisk A/S
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. Sanofi
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives

List of Tables

  • TABLE 1: Diabetes Devices - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2: Diabetes Devices Market Revenue, by Product, 2013 - 2024 (USD Million)
  • TABLE 3: Diabetes Devices Market Revenue, by Region, 2013 - 2024 (USD Million)
  • TABLE 4: Diabetes Devices - Key Market Driver Analysis
  • TABLE 5: North America Diabetes Devices Market Revenue, by Product, 2013 - 2024 (USD Million)
  • TABLE 6: U.S. Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 7: U.S. Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 8: Canada Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 9: Canada Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 10: Europe Diabetes Devices Market Revenue, by Product, 2013 - 2024 (USD Million)
  • TABLE 11: U.K. Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 12: U.K. Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 13: Germany Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 14: Germany Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 15: Asia Pacific Diabetes Devices Market Revenue, by Product, 2013 - 2024 (USD Million)
  • TABLE 16: China Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 17: China Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 18: India Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 19: India Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 20: Latin America Diabetes Devices Market Revenue, by Product, 2013 - 2024 (USD Million)
  • TABLE 21: Brazil Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 22: Brazil Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 23: Mexico Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 24: Mexico Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)
  • TABLE 25: MEA Diabetes Devices Market Revenue, by Product, 2013 - 2024 (USD Million)
  • TABLE 26: South Africa Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2013 - 2024 (USD Million)
  • TABLE 27: South Africa Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1: Diabetes Devices: Market segmentation
  • FIG. 2: Diabetes Devices Market Revenue, 2013 - 2024 (USD Million)
  • FIG. 3: Diabetes Devices: Market Dynamics
  • FIG. 4: Key Opportunities Prioritized
  • FIG. 5: Diabetes Devices - Porter's Analysis
  • FIG. 6: Diabetes Devices - PESTEL analysis
  • FIG. 7: Diabetes Devices: company market share analysis, 2014
  • FIG. 8: Diabetes Devices : Value Chain Analysis
  • FIG. 9: Diabetes Devices Market Revenue Share, by Type, 2014 & 2024
  • FIG. 10: Monitoring and Diagnostic Devices Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 11: Lancets Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 12: Analog Glucose Meter Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 13: Continues Glucose Monitor Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 14: Test Strips Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 15: Insulin Delivery Devices Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 16: Syringe Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 17: Pen Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 18: Pump Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 19: Injector Market Revenue, 2013 to 2024 (USD Million)
  • FIG. 20: Diabetes Devices market share, by region, 2014 & 2024
Back to Top